# Safety and Imaging Study of GC1008 in Glioma

> **NCT01472731** · PHASE2 · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 12 (actual)

## Conditions studied

- Primary Brain Tumors

## Interventions

- **OTHER:** 89Zr-GC1008
- **DRUG:** GC1008

## Key facts

- **NCT ID:** NCT01472731
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01472731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01472731, "Safety and Imaging Study of GC1008 in Glioma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01472731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*